Skip to main content

ALIGN TECHNOLOGY INC

corporate_fare Company Profile

ALIGN TECHNOLOGY INC

ALGN·NASDAQ·Industrial Applications And Services·CIK 0001097149

Align Technology, Inc. is a global medical device company that designs, manufactures, and markets products for orthodontic and restorative dentistry. The company's primary products include Invisalign® clear aligners, used by orthodontists and general dental practitioners (GPs) to treat misaligned teeth. Align also offers Vivera™ retainers for post-treatment retention, iTero™ intraoral scanners and related services for dentistry, and exocad™ computer-aided design and manufacturing (CAD/CAM) software for dental laboratories and practitioners. Align's strategy centers on its Align™ Digital Platform, an integrated suite of technologies and services aimed at providing digital treatment planning and implementation. The company's objectives include establishing Invisalign as a leading solution for malocclusion treatment globally, making iTero intraoral scanners the preferred technology for digital dental scans, and positioning exocad CAD/CAM software as a top choice for dental restorative solutions in labs. The company operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services ("Systems and Services"). For the year ended December 31, 2025, the Clear Aligner segment generated approximately 80% of worldwide net revenues, with Systems and Services accounting for the remaining 20%. Align sells most of its products and services directly to customers, including orthodontists, GPs (such as prosthodontists, periodontists, and oral surgeons), and dental laboratories, through a specialized sales force. Align's corporate headquarters are in Tempe, Arizona, with regional headquarters in Raleigh, North Carolina (Americas), Rotkreuz, Switzerland (EMEA), and Singapore (APAC).

ALIGN TECHNOLOGY INC (NASDAQ:ALGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ALGN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Align Technology's Chief Legal Officer Departs for Illumina
  • EU Launches Antitrust Probe into Align Technology Over Invisalign Sales Tactics
  • Align Technology Announces Chairman Retirement and Successor Appointment
  • Align Technology Reports Strong Q1 Earnings, Significantly Expands Investment Capacity
  • Align Technology's Q1 Revenue, Profit Beat Estimates; FY Guidance Maintained

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.03B
Net Income
$410.35M
Diluted EPS
$5.65
Op. Cash Flow
$593.22M
Free Cash Flow
$490.78M
Gross Profit
$2.71B
Operating Income
$545.75M
Cash & Equivalents
$1.09B
Debt / Equity
0.00×
Net Margin
10.2%
Shares Outstanding
71.36M sh
Source: 10-K · filed 2026-02-27 · accession 0001097149-26-000014
Browse all tickers starting with A →
$175.6
52-week range · as of 2026-07-09 $122 – $208.31
Market cap
$12.58B
Volume
914.1K (0.9× avg)
3-mo avg 1M
Live data · 2026-07-29 10:18 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed ALGN - Latest Insights

ALGN
Jul 08, 2026, 8:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $174.48
Real-time Price: $175.60 info
Change: +$1.12 (+0.64%) info
Market Cap: $12.576B info
ALGN
Jun 30, 2026, 9:25 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $168.00
Real-time Price: $175.60 info
Change: +$7.60 (+5%) info
Market Cap: $12.576B info
ALGN
Jun 18, 2026, 9:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $178.44
Real-time Price: $175.60 info
Change: -$2.84 (-2%) info
Market Cap: $12.576B info
ALGN
May 06, 2026, 4:43 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $173.94
Real-time Price: $175.60 info
Change: +$1.66 (+0.95%) info
Market Cap: $12.576B info
ALGN
Apr 29, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $187.60
Real-time Price: $175.60 info
Change: -$12.00 (-6%) info
Market Cap: $12.576B info
ALGN
Feb 27, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $190.10
Real-time Price: $175.60 info
Change: -$14.50 (-8%) info
Market Cap: $12.576B info
ALGN
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.32
Real-time Price: $175.60 info
Change: +$8.28 (+5%) info
Market Cap: $12.576B info